ConductScience.org, home

Paper7986589

High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection.

Daniel MD and 6 others. AIDS Res Hum Retroviruses, 1994. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. Papers, record 7986589. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7986589

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection.
PubMed
Journal
AIDS Res Hum Retroviruses
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
1.25
iCite
Revised in PubMed
2015-11-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Daniel MDM D
2Mazzara GPG P
3Simon MAM A
4Sehgal PKP K
5Kodama TT
6Panicali DLD L
7Desrosiers RCR C

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SAIDS VaccinesMajor topic
Simian Acquired Immunodeficiency SyndromeMajor topic
Simian Immunodeficiency VirusMajor topic
Animals
Antibody Formation
Blotting, Western
CD4-Positive T-Lymphocytes
Immunization, Secondary
Macaca mulatta
Trachea
Vaccination
Virulence

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI26507NIAID NIH HHSUnited StatesPubMedPubMed
RR00168NCRR NIH HHSUnited StatesP06RR000168PubMed and NIHNIH RePORTER
P40RR000168NIHNIH RePORTER
P51RR000168NIHNIH RePORTER

Download CSV of grants

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
17580087A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.Virology2007https://conductscience.org/library/papers/17580087PubMed
16306607A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.J Virol2005https://conductscience.org/library/papers/16306607PubMed
15975024Non-human primate models for AIDS vaccine research.Curr Drug Targets Infect Disord2005https://conductscience.org/library/papers/15975024PubMed
11462016Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.J Virol2001https://conductscience.org/library/papers/11462016PubMed
10482571Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques.J Virol1999https://conductscience.org/library/papers/10482571PubMed
10233957Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.J Virol1999https://conductscience.org/library/papers/10233957PubMed
9847367Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen.J Virol1999https://conductscience.org/library/papers/9847367PubMed
9811759Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.J Virol1998https://conductscience.org/library/papers/9811759PubMed
9658099Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.J Virol1998https://conductscience.org/library/papers/9658099PubMed
9557706Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.J Virol1998https://conductscience.org/library/papers/9557706PubMed
9499101Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.J Virol1998https://conductscience.org/library/papers/9499101PubMed
9445059Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.J Virol1998https://conductscience.org/library/papers/9445059PubMed
9445045Identification of highly attenuated mutants of simian immunodeficiency virus.J Virol1998https://conductscience.org/library/papers/9445045PubMed
9343164Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.J Virol1997https://conductscience.org/library/papers/9343164PubMed
8986737Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus.Nat Med1997https://conductscience.org/library/papers/8986737PubMed
8648735Simian immunodeficiency virus DNA vaccine trial in macaques.J Virol1996https://conductscience.org/library/papers/8648735PubMed
8627721Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.J Virol1996https://conductscience.org/library/papers/8627721PubMed
8523593Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.J Virol1996https://conductscience.org/library/papers/8523593PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7986589

GET https://conductscience.org/api/papers/v1/7986589/authors